News

Vitro declared that it has received US Patent number 7527971 entitled, “Generation and Differentiation of Adult Stem Cells.” The patent provides protection to a specific cell line derived

MDRNA announced that it has obtained full FDA approval of its Abbreviated New Drug Application (ANDA) for generic calcitonin-salmon nasal spray for the treatment of osteoporosis. Calcitonin-salmon nasal

TOPAZ Technologies, a provider of medical research management software for the Life Sciences industry, has launched Biosafety Solution. The solution automates the medical research study protocol process, from

Umicore and SiliCycle have entered into an exclusive sales representation agreement, under which SiliCycle will commercialize Umicore’ metalbased homogenous catalysts in the North American Life Science Industry. The

Partnerships between suppliers of customized organic-chemical syntheses for the early development stages of active pharmaceutical ingredients will take center stage at the BOS cmc industry forum, on the

SOCMA’s second annual Washington Fly-In, revolved around topics of teauthorizing chemical security rules, modernizing the Toxics Substances Control Act, and protecting workers’ rights threatened by Card Check discussed

CEL-SCI has announced that it is expanding the pre-clinical testing of its flu vaccine, utilizing its proprietary LEAPS technology (Ligand Epitope Antigen Presentation System). The testing is intended

Penwest, Endo and Valeant have announced that Endo has signed an exclusive license with Valeant allowing it to market Opana Er in Canada, Australia and New Zealand. Opana

Raptor has announced that it has signed a collaboration and licensing agreement with Roche to evaluate therapeutic delivery across the blood-brain barrier (BBB), starting with Raptor’s proprietary NeuroTrans